Trials / Withdrawn
WithdrawnNCT01253694
Ranibizumab as a Rescue Therapy for Diabetic Macular Edema
Ranibizumab in Residual Diabetic Macular Edema Following Previous Intravitreal Bevacizumab Therapy
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- New England Retina Associates · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Treatment with Ranibizumab of the residual diabetic edema in patients with failed response to Bevacizumab.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | injection of 0.5 mg of Intravitreal Ranibizumab | Following the sterile technique, intravitreal injection of anti-VEGF is applied |
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2012-06-01
- Completion
- 2012-07-01
- First posted
- 2010-12-03
- Last updated
- 2013-05-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01253694. Inclusion in this directory is not an endorsement.